This inventor holds 1 USPTO granted patent. Top assignee: Kaken Pharmaceutical Company, Ltd.. Active years: 1994.
Company Filing History:
Years Active: 1994
Title: Takao Awa: Innovator in Bone Resorption Inhibitors
Introduction
Takao Awa is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of bone resorption inhibitors. His innovative work has led to the creation of a unique bisphosphonic acid derivative that holds promise for medical applications.
Latest Patents
Takao Awa holds a patent for bisphosphonic acid derivatives, which serve as bone resorption inhibitors. The patent describes a bisphosphonic acid derivative of the formula (I) or a pharmaceutically acceptable salt thereof. This compound includes various functional groups that enhance its efficacy in inhibiting bone resorption.
Career Highlights
Awa is associated with Kaken Pharmaceutical Company, Ltd., where he has been instrumental in advancing research and development in pharmaceutical sciences. His work has contributed to the understanding and treatment of conditions related to bone health.
Collaborations
Throughout his career, Takao Awa has collaborated with esteemed colleagues such as Yoshitaka Ohishi and Makoto Tamura. These partnerships have fostered innovation and have been vital in the progression of their shared research goals.
Conclusion
Takao Awa's contributions to the field of pharmaceuticals, particularly through his patent on bisphosphonic acid derivatives, highlight his role as an influential inventor. His work continues to impact the medical community and offers potential advancements in treating bone-related conditions.